e-CBT for Bipolar Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if electronic cognitive behavioral therapy (e-CBT) effectively helps individuals with Bipolar II Disorder experiencing depressive symptoms. Conducted online, e-CBT offers easier access to therapy compared to traditional in-person sessions. The study will compare two groups: one receiving e-CBT alongside their usual treatment and another continuing with only their usual treatment. Individuals diagnosed with Bipolar II Disorder, currently in a depressive phase, and with reliable internet access may be suitable candidates for this trial. As an unphased study, this trial provides a unique opportunity to access innovative therapy methods that could enhance mental health.
Do I need to stop my current medications to join the trial?
The trial does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual treatment, as the study involves adding e-CBT to your existing care.
What prior data suggests that e-CBT is safe for treating Bipolar Disorder?
Research has shown that electronic Cognitive Behavioral Therapy (e-CBT) is generally easy for patients to manage. Studies have found that e-CBT is as effective as face-to-face CBT in treating depression and anxiety, including for those with bipolar disorder. A review of multiple studies found that e-CBT manages depressive symptoms in bipolar disorder as effectively as other online therapies.
No major reports of serious side effects have emerged from using e-CBT. As a form of talk therapy conducted online, it does not involve medication or physical procedures, reducing the risk of physical side effects. Overall, e-CBT is considered a safe option for mental health treatment.12345Why are researchers excited about this trial?
Researchers are excited about e-CBT for Bipolar Disorder because it offers a new, more accessible way to deliver cognitive-behavioral therapy. Unlike traditional in-person CBT, e-CBT is administered online through OPTT, allowing for flexible scheduling and broader reach to patients who might not have easy access to mental health services. The program features engaging multimedia modules and weekly personalized feedback from clinicians, which could streamline the therapy process and make it more efficient. This method not only saves time for healthcare providers but also ensures that patients receive tailored feedback, potentially enhancing the overall effectiveness of the treatment.
What evidence suggests that e-CBT is effective for treating Bipolar Disorder II with depressive symptoms?
Research has shown that electronic cognitive behavioral therapy (e-CBT), which participants in this trial may receive, can effectively manage depression in individuals with Bipolar II Disorder. Studies indicate that e-CBT works as well as face-to-face CBT for treating depression and anxiety, effectively reducing depressive episodes. One study found that e-CBT helps more people adhere to their therapy, which is crucial for those who struggle to attend regular sessions. Overall, e-CBT offers an easier way to access effective mental health care.12367
Who Is on the Research Team?
Nazanin Alavi
Principal Investigator
Queen's University
Are You a Good Fit for This Trial?
This trial is for individuals with Bipolar Disorder II (BAD-II) currently experiencing depressive symptoms. They must have reliable internet access, understand and speak English, and be able to consent to participate. People are excluded if they've had CBT in the last year, show active suicidal or homicidal thoughts, are in a hypomanic/manic phase, have acute psychosis or severe substance abuse issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive e-CBT through OPTT for 12 weeks, completing weekly modules and homework assignments
Follow-up
Participants are monitored for safety and effectiveness after treatment using MADRS, YMRS, and CGI-BP-M questionnaires
Open-label extension (optional)
Participants in the control group are offered the e-CBT program after the first 12 weeks
What Are the Treatments Tested in This Trial?
Interventions
- e-CBT
e-CBT is already approved in European Union, United States, Canada for the following indications:
- Depression
- Anxiety disorders
- Phobias
- PTSD
- Sleep disorders
- Eating disorders
- Depression
- Anxiety disorders
- Phobias
- PTSD
- Sleep disorders
- Eating disorders
- Depression
- Anxiety disorders
- Phobias
- PTSD
- Sleep disorders
- Eating disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dr. Nazanin Alavi
Lead Sponsor
Dr. Nazanin Alavi
Lead Sponsor
Queen's University
Lead Sponsor
Online PsychoTherapy Clinic
Collaborator